It's The First Drug Shown To Slow Alzheimer's. Why Is It Off To A Slow Start?
The first drug shown to slow Alzheimerβs disease hit the U.S. market over a year ago, but sales have lagged, major hospital systems have taken months to start using it and some insurers have rejected coverage.
